1. Home
  2. RKDA vs MBIO Comparison

RKDA vs MBIO Comparison

Compare RKDA & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcadia Biosciences Inc.

RKDA

Arcadia Biosciences Inc.

HOLD

Current Price

$2.56

Market Cap

5.8M

Sector

Industrials

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$1.00

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RKDA
MBIO
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8M
4.7M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
RKDA
MBIO
Price
$2.56
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.8K
91.4K
Earning Date
11-07-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,173,000.00
N/A
Revenue This Year
$21.31
N/A
Revenue Next Year
$28.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.31
N/A
52 Week Low
$2.53
$0.89
52 Week High
$6.71
$21.95

Technical Indicators

Market Signals
Indicator
RKDA
MBIO
Relative Strength Index (RSI) 23.74 34.37
Support Level $3.50 $1.05
Resistance Level $3.50 $1.14
Average True Range (ATR) 0.26 0.07
MACD -0.09 -0.01
Stochastic Oscillator 2.27 9.37

Price Performance

Historical Comparison
RKDA
MBIO

About RKDA Arcadia Biosciences Inc.

Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: